Regeneron Pharmaceuticals Inc (REGN) — Net Asset Momentum
Regeneron Pharmaceuticals Inc (REGN) recorded a net asset momentum of 6.5% as of December 2025, with net assets of $31.26 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Regeneron Pharmaceuticals Inc (REGN) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Regeneron Pharmaceuticals Inc Net Asset Momentum (1990–2025)
This chart tracks Regeneron Pharmaceuticals Inc's year-over-year net asset growth across 36 annual reporting periods from 1990 to 2025. The most recent momentum reading is +6.5%, with net assets of $31.26 Billion USD as of December 2025. Read Regeneron Pharmaceuticals Inc debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Regeneron Pharmaceuticals Inc (1990–2025)
The table below shows the complete annual net asset history for Regeneron Pharmaceuticals Inc from 1990 to 2025, covering 36 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Regeneron Pharmaceuticals Inc market cap and net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $31.26 Billion | $40.56 Billion | $9.30 Billion | ▲ +6.5% |
| 2024 | $29.35 Billion | $37.76 Billion | $8.41 Billion | ▲ +13.0% |
| 2023 | $25.97 Billion | $33.08 Billion | $7.11 Billion | ▲ +14.6% |
| 2022 | $22.66 Billion | $29.21 Billion | $6.55 Billion | ▲ +20.8% |
| 2021 | $18.77 Billion | $25.43 Billion | $6.67 Billion | ▲ +70.2% |
| 2020 | $11.03 Billion | $17.16 Billion | $6.14 Billion | ▼ -0.6% |
| 2019 | $11.09 Billion | $14.81 Billion | $3.72 Billion | ▲ +26.6% |
| 2018 | $8.76 Billion | $11.73 Billion | $2.98 Billion | ▲ +42.5% |
| 2017 | $6.14 Billion | $8.76 Billion | $2.62 Billion | ▲ +38.1% |
| 2016 | $4.45 Billion | $6.97 Billion | $2.52 Billion | ▲ +21.7% |
| 2015 | $3.65 Billion | $5.61 Billion | $1.95 Billion | ▲ +43.8% |
| 2014 | $2.54 Billion | $3.87 Billion | $1.33 Billion | ▲ +30.2% |
| 2013 | $1.95 Billion | $2.95 Billion | $998.94 Million | ▲ +56.7% |
| 2012 | $1.25 Billion | $2.08 Billion | $835.11 Million | ▲ +156.4% |
| 2011 | $485.73 Million | $1.32 Billion | $837.85 Million | ▼ -8.0% |
| 2010 | $527.82 Million | $1.09 Billion | $561.62 Million | ▲ +33.0% |
| 2009 | $396.76 Million | $741.20 Million | $344.44 Million | ▼ -5.3% |
| 2008 | $418.85 Million | $670.04 Million | $251.19 Million | ▼ -9.0% |
| 2007 | $460.27 Million | $936.26 Million | $475.99 Million | ▲ +112.5% |
| 2006 | $216.62 Million | $585.09 Million | $368.47 Million | ▲ +90.0% |
| 2005 | $114.00 Million | $423.50 Million | $309.50 Million | ▼ -37.5% |
| 2004 | $182.54 Million | $473.11 Million | $290.56 Million | ▲ +32.6% |
| 2003 | $137.64 Million | $479.56 Million | $341.91 Million | ▼ -5.7% |
| 2002 | $145.98 Million | $391.57 Million | $245.59 Million | ▼ -45.2% |
| 2001 | $266.36 Million | $495.40 Million | $229.04 Million | ▲ +46.2% |
| 2000 | $182.13 Million | $208.27 Million | $26.14 Million | ▲ +66.3% |
| 1999 | $109.50 Million | $137.00 Million | $27.50 Million | ▼ -16.5% |
| 1998 | $131.20 Million | $156.90 Million | $25.70 Million | ▼ -5.5% |
| 1997 | $138.90 Million | $168.40 Million | $29.50 Million | ▲ +29.9% |
| 1996 | $106.90 Million | $137.60 Million | $30.70 Million | ▲ +57.4% |
| 1995 | $67.90 Million | $93.80 Million | $25.90 Million | ▲ +1.2% |
| 1994 | $67.10 Million | $94.20 Million | $27.10 Million | ▼ -31.8% |
| 1993 | $98.40 Million | $117.60 Million | $19.20 Million | ▲ +12.8% |
| 1992 | $87.20 Million | $97.90 Million | $10.70 Million | ▼ -17.9% |
| 1991 | $106.20 Million | $114.00 Million | $7.80 Million | ▲ +770.5% |
| 1990 | $12.20 Million | $25.40 Million | $13.20 Million | — |